BRIEF published on 08/27/2026 at 15:54, 14 days 16 hours ago Vanguard Group Discloses Position in Prologis, Inc. Takeover Code Securities Disclosure Vanguard Group Stock Positions Prologis
BRIEF published on 08/27/2026 at 15:54, 14 days 16 hours ago The Vanguard Group Reports on DNO Iraq AS Stakes Form 8.3 Securities Disclosure Vanguard Group Investment Position DNO Iraq AS
BRIEF published on 08/27/2026 at 15:52, 14 days 16 hours ago Vanguard Discloses Position in Beazley plc Ordinary Shares Disclosure The Vanguard Group Takeover Code Beazley Plc
BRIEF published on 08/27/2026 at 15:52, 14 days 16 hours ago The Vanguard Group Discloses Stake in Rotork plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Rotork Plc
BRIEF published on 08/27/2026 at 15:51, 14 days 16 hours ago The Vanguard Group Discloses Position in Gamma Communications Form 8.3 The Vanguard Group Takeover Code Securities Disclosure Gamma Communications
BRIEF published on 08/27/2026 at 15:51, 14 days 16 hours ago The Vanguard Group Discloses Position in Schroders plc Disclosure Takeover Code Schroders Plc Vanguard Group Stock Position
BRIEF published on 08/27/2026 at 15:50, 14 days 16 hours ago The Vanguard Group Discloses Position in Tate & Lyle Form 8.3 Takeover Code Vanguard Group Share Transactions Tate & Lyle
PRESS RELEASE published on 08/27/2026 at 15:49, 14 days 16 hours ago Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc. The Vanguard Group, Inc. discloses a 13.50% interest in Prologis, Inc. and dealings in relevant securities. Public disclosure under Rule 8.3 Rule 8.3 Vanguard Group Dealings Interests Prologis Inc.
BRIEF published on 08/27/2026 at 15:49, 14 days 16 hours ago The Vanguard Group Discloses Position in Spire Healthcare Group Takeover Code Vanguard Group Spire Healthcare Stock Transactions Shareholding Disclosure
PRESS RELEASE published on 08/27/2026 at 15:49, 14 days 16 hours ago Form 8.3 - The Vanguard Group, Inc.: DNO Iraq AS (a wholly owned subsidiary of DNO ASA) The Vanguard Group, Inc. discloses a 3.49% stake in DNO Iraq AS, a subsidiary of DNO ASA. Details in Form 8.3 filing on 27-Aug-2026 Form 8.3 Vanguard Group Financial Disclosure Stake Disclosure DNO Iraq AS
Published on 09/11/2026 at 04:00, 4 hours 2 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 9 hours 37 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 16 hours 42 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 17 hours 2 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 07:30, 31 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 7 hours 56 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/10/2026 at 22:39, 9 hours 22 minutes ago EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law
Published on 09/10/2026 at 22:10, 9 hours 51 minutes ago flatexDEGIRO with changes to the Supervisory Board
Published on 09/11/2026 at 07:00, 1 hour 2 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 12 hours 32 minutes ago Availability of the 2026 Interim Financial Report
